Related Experiment Video
Updated: Nov 1, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Molecular Diagnosis of Yeast Infections
P Lewis White1, Jessica S Price1, Alan Cordey1
1Mycology Reference Laboratory, Public Health Wales, Microbiology Cardiff, UHW, Heath Park, Cardiff, CF14 4XW UK.
Purpose Of Review:
The use of molecular tests to aid the diagnosis of invasive yeast infection, in particular invasive candidosis, has been described for over two decades, yet widespread application is limited, and diagnosis remains heavily dependent on classical microbiology. This article will review developments from the past decade in attempt to build on existing knowledge. It will highlight clinical performance and limitations while reviewing developments on recognized procedures; it will also provide insight into novel approaches incorporated in response to clinical demand (e.g. C. auris and antifungal resistance) or technological advances (e.g. next-generation sequencing).
Recent Findings:
Limited methodological standardization and, until recently, unavailability of commercial options have hindered the integration of molecular diagnostics for yeasts. The development of certain, novel commercial methods has received considerable evaluation allowing a greater understanding of individual assay performance, but widespread multicentre evaluation of most commercial kits is lacking. The detection of emerging pathogens (e.g. C. auris) has been enhanced by the development of molecular tests. Molecular methods are providing a better understanding of the mycobiome, mechanisms of resistance and epidemiology/phylogeny.
Summary:
Despite over two decades of use, the incorporation of molecular methods to enhance the diagnosis of yeast infections remains limited to certain specialist centres. While the development of commercial tests will provide stimulus for broader application, further validation and reduced costs are required. Over the same period of time, Aspergillus PCR has become more widely accepted driven by international efforts to standardize methodology; it is critical that yeast PCR follows suit. Next-generation sequencing will provide significant information on the mycobiome, antifungal resistance mechanism and even broad-range detection directly from the specimen, which may be critical for the molecular detection of yeasts other than Candida species, which is currently limited.
Insights
Molecular diagnostics for invasive yeast infections show promise but face limited adoption due to standardization issues. Further validation and cost reduction are needed for broader clinical use, especially for emerging pathogens like Candida auris.
Area of Science:
- Clinical Microbiology
- Molecular Diagnostics
- Mycology
Background:
- Invasive yeast infections, particularly invasive candidosis, have relied on classical microbiology for diagnosis for over 20 years.
- Molecular diagnostic tests for yeasts have been available for decades but face limited widespread clinical application.
- Diagnosis remains heavily dependent on traditional culture-based methods, highlighting a need for improved diagnostic strategies.
Purpose of the Study:
- To review developments in molecular diagnostics for yeast infections over the past decade.
- To highlight the clinical performance, limitations, and novel approaches in yeast molecular diagnostics.
- To address emerging challenges such as Candida auris and antifungal resistance.
Main Methods:
- Review of recent literature on molecular diagnostic methods for yeast infections.
- Evaluation of commercial molecular assays and their performance.
- Analysis of technological advancements, including next-generation sequencing.
Main Results:
- Limited methodological standardization and lack of commercial options have hindered molecular diagnostic integration.
- Novel commercial methods show promise but require broader multicenter evaluation.
- Molecular tests have improved the detection of emerging pathogens like Candida auris and understanding of antifungal resistance and epidemiology.
Conclusions:
- Molecular methods for yeast infection diagnosis are limited to specialist centers, requiring further validation and cost reduction for broader use.
- Standardization efforts, similar to Aspergillus PCR, are critical for yeast PCR adoption.
- Next-generation sequencing offers potential for broad-range detection and insights into mycobiome and antifungal resistance.
Related Concept Videos
Yeast Signaling
Modern Molecular Taxonomy

